These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2566943)

  • 41. 5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms.
    Berg KA; Clarke WP; Chen Y; Ebersole BJ; McKay RD; Maayani S
    Mol Pharmacol; 1994 May; 45(5):826-36. PubMed ID: 8190100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Free intracellular Ca2+ concentration and growth hormone (GH) release from purified rat somatotrophs. III. Mechanism of action of GH-releasing factor and somatostatin.
    Lussier BT; French MB; Moor BC; Kraicer J
    Endocrinology; 1991 Jan; 128(1):592-603. PubMed ID: 1670926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Somatostatin blocks Ca2+ action potential activity in prolactin-secreting pituitary tumor cells through coordinate actions on K+ and Ca2+ conductances.
    Mollard P; Vacher P; Dufy B; Barker JL
    Endocrinology; 1988 Aug; 123(2):721-32. PubMed ID: 2456203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calmodulin dependence of somatostatin release stimulated by growth hormone-releasing factor.
    Aguila MC; McCann SM
    Endocrinology; 1988 Jul; 123(1):305-9. PubMed ID: 2898360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calmodulin inhibitors decrease the CRF-and AVP-induced ACTH release in vitro: interaction of calcium-calmodulin and the cyclic AMP system.
    Murakami K; Hashimoto K; Ota Z
    Neuroendocrinology; 1985 Jul; 41(1):7-12. PubMed ID: 2991797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of lens cyclic nucleotide metabolism by Ca2+ plus calmodulin.
    Louis CF; Mickelson JR; Turnquist J; Hur KC; Johnson R
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):806-14. PubMed ID: 3032838
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Somatostatin inhibition of pancreatic glucagon release from monolayer cultures and interactions with calcium.
    Wollheim CB; Blondel B; Renold AE; Sharp GW
    Endocrinology; 1977 Sep; 101(3):911-9. PubMed ID: 330154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activity-dependent somatostatin gene expression is regulated by cAMP-dependent protein kinase and Ca2+-calmodulin kinase pathways.
    Sánchez-Muñoz I; Sánchez-Franco F; Vallejo M; Fernández A; Palacios N; Fernández M; Cacicedo L
    J Neurosci Res; 2010 Mar; 88(4):825-36. PubMed ID: 19859966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Somatostatin inhibits cAMP-dependent and cAMP-independent calcium influx in the clonal pituitary tumor cell line AtT-20 through the same receptor population.
    Reisine T; Wang HL; Guild S
    J Pharmacol Exp Ther; 1988 Apr; 245(1):225-31. PubMed ID: 2896236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calmodulin modulates prolactin secretion in vitro: studies with calmodulin containing liposomes.
    Schettini G; Florio T; Meucci O; Landolfi E; Cronin MJ; MacLeod RM
    Life Sci; 1987 Nov; 41(22):2437-44. PubMed ID: 2824954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of nicotine-evoked dopamine release from PC12 cells.
    Courtney ND; Howlett AC; Westfall TC
    Life Sci; 1991; 48(17):1671-8. PubMed ID: 1850061
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional coupling between the cyclic adenosine monophosphate pathway and cholecystokinin secretion in RIN cells.
    Aucouturier S; Bernard C; Roche C; Philippe J; Chayvialle JA; Cuber JC
    Biochem Biophys Res Commun; 1994 May; 200(3):1382-90. PubMed ID: 8185590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of calmodulin antagonists on hormone release and cyclic AMP levels in GH3 pituitary cells.
    Sletholt K; Haug E; Gordeladze J; Sand O; Gautvik KM
    Acta Physiol Scand; 1987 Jun; 130(2):333-43. PubMed ID: 3037857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of protein kinase C in the UTP-mediated potentiation of cyclic AMP accumulation in mouse J774 macrophages.
    Lin WW; Chen BC
    Br J Pharmacol; 1997 Aug; 121(8):1749-57. PubMed ID: 9283713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms.
    Xiao D; Chu MM; Lee EK; Lin HR; Wong AO
    Neuroendocrinology; 2002 Nov; 76(5):325-38. PubMed ID: 12457043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of calmodulin antagonists on prostaglandin E2-induced responses in rat calvarial bone cells.
    Dziak R; Farr D; Zoghby G; Weinfeld N
    Arch Oral Biol; 1986; 31(6):391-7. PubMed ID: 3019287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of plasma membrane-located calmodulin in the response decay of cyclic nucleotide-gated cation channel of cultured carrot cells.
    Kurosaki F; Kaburaki H; Nishi A
    FEBS Lett; 1994 Mar; 340(3):193-6. PubMed ID: 8131844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trypsin-induced increase in cyclic AMP concentration in rat thymocytes. An effect independent of calcium and calmodulin.
    Segal J
    Biochem J; 1986 Nov; 239(3):603-7. PubMed ID: 3030267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anticonvulsants inhibit rat neuronal somatostatin release.
    Richardson SB; Twente S
    Brain Res; 1992 Feb; 571(2):230-4. PubMed ID: 1351779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Somatostatin release from dispersed hypothalamic cells - effects of membrane depolarization, calcium and glucose deprivation.
    Richardson SB; Greenleaf P; Hollander CS
    Brain Res; 1983 Apr; 266(1):75-81. PubMed ID: 6133593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.